128438-01-7 Usage
General Description
"(Z)-2-(2-Aminothiazole-4-yl-)-2-trityloxyimino acetic acid is a chemical compound that belongs to the class of organic compounds known as trityl-amino acids and derivatives. Its systematic name is (Z)-2-(2-Aminothiazole-4-yl)-2-(triphenylmethoxy)iminoacetic acid. It is potentially used in the field of biochemistry, particularly in pharmaceutical research for its possible biological activities. It consists of a trityl group, an aminothiazole ring, and an acetic acid group connected by an oxyimino linker. Its chemical properties and structure play important roles in its potential functions and applications. However, detailed information about its functions, uses, and safety profiles might be limited therefore further studies are needed.
Check Digit Verification of cas no
The CAS Registry Mumber 128438-01-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,4,3 and 8 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 128438-01:
(8*1)+(7*2)+(6*8)+(5*4)+(4*3)+(3*8)+(2*0)+(1*1)=127
127 % 10 = 7
So 128438-01-7 is a valid CAS Registry Number.
InChI:InChI=1/C24H19N3O3S/c25-23-26-20(16-31-23)21(22(28)29)27-30-24(17-10-4-1-5-11-17,18-12-6-2-7-13-18)19-14-8-3-9-15-19/h1-16H,(H2,25,26)(H,28,29)/b27-21-
128438-01-7Relevant articles and documents
PROCESS FOR PREPARING 2-AMINOTHIAZOL-4-YL-ACETIC ACID DERIVATES
-
, (2011/04/18)
The invention provides a process for preparing a (2-aminothiazol-4-yl)-triarylmethyloxy- iminoacetic acid of the formula (I) or an ester thereof of the formula (II) wherein R1, R2 and R3 independently are optionally substi
Process for the preparation of cephem prodrug esters
-
, (2008/06/13)
The invention relates to a process for the preparation of cephem prodrug esters of the formula: STR1 in which R1 is C1 -C5 -alkanoyloxy-C1 -C3 -alkyl or C1 -C5 -alkoxycarbonyloxy
Process for cephem prodrug esters
-
, (2008/06/13)
A process for the selective formation of oximino o-protected derivatives of lower alkyl 2-(2-aminothiazol-4-yl)-2-oximinoacetates, and their use in the acylation of 7-amino-cephalosporin compounds is disclosed.